1. INTRODUCTION {#sec1}
===============

Femoral varus osteotomy is a method to manage pre-arthritic and early arthritic hip conditions, including primary osteoarthritis, secondary osteoarthritis due to developmental dysplasia of the hip joint, and avascular necrosis; these can be challenging due to the relatively young patient age at presentation, high variation in structural deformities, and increased risk of secondary hip osteoarthritis over time \[[@r1]-[@r8]\].

Some patients experience a change in their hip disease after osteotomy, and several lines of evidence indicate good clinical results following femoral varus osteotomy \[[@r1]-[@r8]\]. However, femoral varus osteotomy does not always enable full recovery; some patients require further treatment with Total Hip Arthroplasty (THA) for hip osteoarthritis following femoral varus osteotomy. Previous studies have reported success rates for femoral varus osteotomy of 73%-90% \[[@r7], [@r9]\].

THA for patients with a history of femoral osteotomy is technically difficult, and there are more complications associated with this procedure than with traditional THA. Furthermore, THA performed after intertrochanteric osteotomy for osteoarthritis is known to have higher perioperative and postoperative complication rates (17%-25%) than THA in patients without a history of osteotomy \[[@r10], [@r11]\]. Femoral varus osteotomy procedures have been described previously \[[@r1], [@r12]\] and can be divided into two groups: curved and wedge varus osteotomy. Curved varus osteotomy was first described by Nishio and Sugioka \[[@r1]\]; this procedure retains leg length after the operation and protects against Trendelenburg's sign. There have been a few reports of THA after failed femoral varus osteotomy \[[@r13]\]; however, differences in clinical and radiographic results between patients who failed curved varus osteotomy and those who failed wedge varus osteotomy are unknown.

We herein report clinical and radiographic outcomes of THA after failed femoral varus osteotomy, comparing clinical and radiographic outcomes between patients who had failed curved varus osteotomy and those who had failed wedge varus osteotomy.

2. MATERIAL AND METHODS {#sec2}
=======================

The study protocol adhered to the ethical guidelines of the 1975 Declaration of Helsinki, and the institutional review board approved this study. Written informed consent was obtained from all participants.

Between February 1999 and December 2011, we performed cementless THA in 22 hips (19 patients) after failed intertrochanteric varus osteotomy. All varus osteotomy procedures were performed at other hospitals, except for one hip. We excluded four hips (four patients) that we were unable to monitor for more than 4 years after THA. We enrolled the remaining 18 hips in 15 patients in the present study.

We adopted the posterolateral approach in all cases, due to the advantages of using an extensive approach for the greater trochanter and proximal femur. All patients received only spinal anesthesia. Fourteen hips underwent conventional THA, and four hips underwent THA with subtrochanteric corrective osteotomy. In three hips, V-shaped subtrochanteric corrective osteotomy was performed by using a device to help ensure the performance of an accurate osteotomy based on the shape of the femur medullary cavity \[[@r14]\] (Fig. **[1](#F1){ref-type="fig"}**). In one hip, transverse subtrochanteric corrective osteotomy was performed, because the corrective osteotomy was excessively proximal for V-shaped osteotomy. The decision to perform subtrochanteric corrective osteotomy was made by the operator. Following conventional THA, all patients were allowed full weight-bearing 2 days after the operation. Following THA with subtrochanteric corrective osteotomy, patients were allowed to use a wheelchair 2 days after the operation; partial weight-bearing with crutches or a walker was allowed 1 week after the operation, while standing and walking with full weight-bearing was allowed 3 weeks after the operation.

All of the operations were performed by using a cementless femoral component (a PerFix-HA femoral component; Kyocera, Kyoto, Japan) with a 28- or 32-mm zirconia ball and an AMS-HA acetabular shell (Kyocera, Kyoto, Japan) with an AMS (cross-linked ultra-high-molecular-weight polyethylene liner) liner (Kyocera, Kyoto, Japan). All hips were evaluated by using the Japanese Orthopaedic Association (JOA) hip score before THA and last follow-up. JOA hip score consisted of four categories, with 100 points regarded as full marks: pain (40 points), range of motion (20 points), walking ability (20 points), and activities of daily living (20 points).

Routine radiographic examinations included anteroposterior and frog-leg lateral radiographs. Acetabular components were evaluated at the most recent follow-up for evidence of migration, in accordance with the method of Carlsson and Gentz \[[@r15]\]. The bone-metal interface was evaluated at the most recent follow-up for the presence and progression of radiolucent lines in the three zones described by DeLee and Charnley \[[@r16]\]. The femoral component was evaluated for changes in position, subsidence, and radiolucencies in the seven zones described by Gruen *et al*. \[[@r17]\]. Stability of the femoral component was assessed as bone-ingrown fixation, stable fixation, or unstable fixation, in accordance with the fixation/stability score described by Engh *et al*. \[[@r18]\]. The grade of dislocation was evaluated by using Crowe's classification \[[@r19]\].

Abduction and anteversion angles of the acetabular components and alignments of the femoral stems were measured on the most recent anteroposterior radiographs. The abduction angle of the acetabular component was measured by using the method described by Engh *et al*. \[[@r20], [@r21]\]. Anteversion of the acetabular component was calculated by using the method of Widmer \[[@r22]\]. Cups with an abduction angle of ≤30° or ≥50° \[[@r23]\], or with an anteversion angle of ≤5° or ≥25° \[[@r24]\], were considered outliers of optimal cup position. Stem alignment was determined by measuring the angle formed between the longitudinal axis of the femoral stem and the longitudinal axis of the femoral canal \[[@r25], [@r26]\]. The alignment of the stem was classified as neutral, valgus (\>5° of lateral deviation), or varus (\>5° of medial deviation) \[[@r25], [@r26]\].

Subjects were divided into two groups: hips that underwent curved varus osteotomy (Curved group) (Fig. **[2](#F2){ref-type="fig"}**), and hips that underwent wedge varus osteotomy (Wedge group) (Fig. **[3](#F3){ref-type="fig"}**). We compared the above data between the two groups.

Statistical Package for Social Sciences (SPSS) version 19 software program (IBM SPSS, Chicago, IL, USA) was used for statistical analyses of data. An unpaired *t*-test and the χ^2^ test were used to compare each of the parameters between the groups. A paired *t*-test was used to compare each of the parameters before and after THA. P values \< 0.05 were considered to indicate statistical significance.

3. RESULTS {#sec3}
==========

3.1. Clinical Evaluation {#sec3.1}
------------------------

Regarding the patients' background, there were no significant differences between the two groups (Table **[1](#T1){ref-type="table"}**). We noted no significant differences between the two groups in terms of perioperative results; however, all four femoral subtrochanteric corrective osteotomies combined with THA were performed in the Wedge group (Table **[2](#T2){ref-type="table"}**). There were 13 females and two males, and the average age at the time of the operation was 56 years old (range, 25-74 years old). The average duration of follow-up monitoring was 72.2 months (range, 54-91 months). Indications for the procedure were severe hip pain and/or considerable difficulty walking and performing daily activities. Mean duration between osteotomy and THA was 29.1 years (range, 11-51 years). In five hips, remaining implants were observed on radiographs before the operation (four plates and one screw). Chiari osteotomies were performed at the pelvic site in two hips.

Average total JOA hip score for all patients improved from 45.1 (range 26-77) preoperatively to 85.1 (range 62-96) at the latest follow-up (p\<0.01). There was no statistically significant difference in each category; however, pain score was greatly improved (in all subjects and in a subgroup of subjects that excluded subtrochanteric osteotomy cases). After excluding four cases treated with femoral subtrochanteric corrective osteotomy, average total JOA hip score improved from 48.9 to 87.1 (p\<0.01). Before THA, there were no significant differences between the two groups in average total JOA hip score or any of the four subcategories. However, at the latest follow-up, we noted significant differences between the groups in average total JOA hip score (p\<0.01) and one subcategory (gait) (p\<0.01) (Table **[3](#T3){ref-type="table"}**). Even after excluding four cases treated with femoral subtrochanteric corrective osteotomy, significant differences remained between the two groups in average total JOA hip score and gait subcategory at the latest follow-up. The average total JOA hip scores and gait subcategory values (Wedge group *vs*. Curved group) were 84.4 *vs*. 94.0 and 15.7 *vs*. 20.0, respectively. There were significant differences (p\<0.01 and p\<0.01, respectively). Regarding complications, there was one case of dislocation and transient paresthesia in one patient, who was in the Wedge group and underwent 3.7-cm leg lengthening. There were no cases of infection.

3.2. Radiographic Evaluation {#sec3.2}
----------------------------

No acetabular components showed any evidence of migration, loosening, or radiolucent lines of \<2-mm thickness. One femoral component used in a case of femoral subtrochanteric corrective osteotomy moved toward the varus direction postoperatively; it was fixed with an optimum interface at the latest follow-up. Other femoral components were also fixed with an optimum interface at the latest follow-up. Bony union at the osteotomy site was achieved in all cases with subtrochanteric osteotomy. There were significant differences in cup abduction between the two groups; the average degree of cup anteversion in the Wedge group was significantly larger than that in the Curved group (P\<0.05). There were no significant differences between the two groups regarding the number of cups in malposition (degree of abduction and anteversion), the number of stems in malposition (varus-valgus), or the number of stems in malposition (flexion-extension) (Table **[4](#T4){ref-type="table"}**). However, all stems of three hips in malposition belonged to the Wedge group (Fig. **[4](#F4){ref-type="fig"}**); two hips exhibited Crowe grade 1 and one hip exhibited grade 3. One stem in malposition (varus-valgus) was observed in a hip that underwent femoral subtrochanteric corrective osteotomy. Two stems in malposition (flexion-extension) were observed in hips that underwent femoral subtrochanteric corrective osteotomy. There were no cases of revision at the last follow-up.

4. DISCUSSION {#sec4}
=============

There have been several reports regarding outcomes of THA after failed femoral osteotomy, including valgus osteotomy, anterior rotational osteotomy, and Schanz osteotomy \[[@r26]-[@r28]\]. However, few studies have described outcomes of THA after failed femoral varus osteotomy; thus far, only one study has examined the results of conversion THA after curved varus osteotomy \[[@r13]\]. Takegami *et al*. reported that THA after failed curved varus osteotomy provides satisfactory clinical outcomes; Harris hip score significantly improved from 53.8 to 89.7 \[[@r13]\].

There are two types of varus osteotomy: curved \[[@r1]\] and wedge \[[@r12]\] osteotomy. Curved osteotomy has an advantage over wedged varus osteotomy in the degree of leg length discrepancy after the operation \[[@r8]\]. However, good clinical results have been reported after both curved and wedge varus osteotomy procedures. Okura *et al*. \[[@r7]\] reported a 90% survival rate at 10-year follow-up of femoral curved osteotomy for osteonecrosis of the femoral head. In addition, Ito *et al*. \[[@r4]\] reported an 81% survival rate at 10 years, 60% at 20 years, and 50% at 25 years after femoral wedge osteotomy for developmental dysplasia of the hip joint.

THA after several kinds of osteotomy is accompanied by various technical difficulties \[[@r10], [@r11], [@r27]-[@r29]\]. However, the effects of differences in varus osteotomy procedures on surgical difficulties of THA are unclear. Standardizing the surgical technique and implant specifications is important for the comparison of results after THA among varus osteotomy procedures. Design of the hip prosthesis has varied among patients in most reports; however, we used the same cementless prosthesis design in all cases in the present study.

In our study, femoral subtrochanteric corrective osteotomy combined with THA was performed in four hips. The indication for femoral subtrochanteric osteotomy was a requirement to shorten the femur for a highly dislocated hip or to correct the shape of the femur for a deformed proximal femur \[[@r30]\]. Some papers have reported good clinical and radiographic results of THA combined with subtrochanteric osteotomy; however, this is a technically demanding treatment option with characteristic complications, such as pseudarthrosis and intraoperative fracture \[[@r29]-[@r31]\].

Notably, total JOA hip score of the Curved group at the latest follow-up was significantly higher than the score in the Wedge group. Subtrochanteric osteotomy may thus have reduced total JOA hip score in the Wedge group; however, we also noted significant differences in total JOA hip score between the two groups, even after excluding subtrochanteric osteotomy cases. This suggests that surgeons should choose curved varus osteotomy with the objective of obtaining better clinical results.

Regarding the stem position, there were no significant differences between the two groups; however, stems that deviated from normal range were all in the Wedge group. Wedge varus osteotomy may thus hamper accurate insertion of the stem into the femoral canal.

Several limitations were associated with the present study. First, the diseases that were indications of varus osteotomy remain unknown. Second, the study group was relatively small (18 hips). However, this is the first report comparing clinical and radiographic results between wedge and curved varus osteotomy. Third, the average follow-up period was 72 months, which is relatively brief. Further, investigations are needed to establish the clinical results in detail and to outline a more specific clinical therapeutic strategy.

CONCLUSION
==========

To our knowledge, this is the first comparison of clinical and radiographic results after THA following failed curved or wedge varus osteotomy. When surgeons perform femoral varus osteotomy, they should consider the possibility of future conversion to THA. The present findings suggest that curved varus osteotomy is more suitable than wedge osteotomy for future conversion to THA.
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###### 

Demographic characteristics of the study participants.

  ---------------------------------------------------------------------------------------------------------------
  --                                                   Total           Wedge Group     Curved Group     P Value
  ---------------------------------------------------- --------------- --------------- ---------------- ---------
  Number of patients                                   15              12              3                

  Number of hips                                       18              14              4                

  Sex (male, female)                                   2, 16           2, 12           0, 4             0.043

  Follow-up period, months\                            72.2 ± 11.1,\   70.1 ± 11.6,\   79.5 ± 5.0,\     0.143
  (mean ± SD, range)                                   54-91           54-91           72-84            

  Body weight, kg\                                     57.8 ± 15.3,\   58.3 ± 16.7,\   55.8 ± 10.8,\    0.780
  (mean ± SD, range)                                   42.0-103.9      42-103.9        49.7-72.0        

  Body height, cm\                                     152.7 ± 7.3,\   152.6 ± 5.6,\   152.9 ± 12.9,\   0.969
  (mean ± SD, range)                                   144.0-172.3     144.0-163.0     145.7-172.3      

  BMI, kg/m^2^\                                        24.6 ± 5.0,\    24.8 ± 5.7,\    23.7 ± 0.7,\     0.495
  (mean ± SD, range)                                   19.5-39.1       19.5-39.1       23.1-24.4        

  Age at THA, years\                                   56 ± 11,\       57.1 ± 11.8,\   52.8 ± 0.5,\     0.485
  (mean ± SD, range)                                   25-74           25-74           52-53            

  Age at osteotomy, years\                             27.1 ± 10.8,\   27.0 ± 11.6,\   27.3 ± 9.1,\     0.969
  (mean ± SD, range)                                   10-46           10-46           14-35            

  Duration after osteotomy, years (mean ± SD, range)   29.1 ± 9.0,\    30.1 ± 9.0,\    25.5 ± 9.4,\     0.386
                                                       11-51           11-51           17-39            

  Osteotomy at pelvic side, n (%)                      2 (11%)         1(7%)           1(25%)           0.316

  Remaining implants, n (%)                            5 (28%)         5 (36%)         0(0%)            0.160

  Crowe classification Grade 1                         7               6               1                

                                    Grade 2            6               4               2                

                                    Grade 3            3               2               1                

                                    Grade 4            2               2               0                
  ---------------------------------------------------------------------------------------------------------------

THA: total hip arthroplasty

SD: standard deviation

###### 

Results of perioperative findings.

  -------------------------------------------------------------------------------------------------------------
  --                                            Total             Wedge Group       Curved Group      P Value
  --------------------------------------------- ----------------- ----------------- ----------------- ---------
  Number of patients                            15                12                3                 

  Number of hips                                18                14                4                 

  Operation time, min\                          70.5 ± 27.2\      73.8 ± 29.1,\     59.0 ± 17.0,\     0.352
  (mean ± SD, range)                            36-134            37-134            36-770            

  Total blood loss, g\                          817.8 ± 381.1\    776.4 ± 365.9,\   963.0 ± 454.7,\   0.404
  (mean ± SD, range)                            260-1620          260-1532          577-1620          

     Perioperative blood loss, g\               422.8 ± 276.2\    396.4 ± 257.7,\   515.5 ± 360.6,\   0.464
     (mean ± SD, range)                         118-1040          118-842           220-1040          

     Postoperative blood loss, g\               395.0 ± 284.5,\   380.0 ± 308.7,\   447.5 ± 202.4,\   0.689
     (mean ± SD, range)                         0-1030            0-1030            150-580           

  Subtrochanteric corrective osteotomy, n (%)   4 (22%)           4 (29%)           0 (0%)            0.160

  Cup size, mm\                                 48.8 ± 2.6,\      48.3 ± 1.3,\      50.5 ± 5.0,\      0.443
  (mean ± SD, range)                            46-58             46-50             48-58             

  Stem distal size, mm\                         11.1 ± 1.4,\      11.0 ± 1.3,\      11.5 ± 1.9,\      0.548
  (mean ± SD, range)                            9-14              9-13              10-14             

  Ball size, mm\                                28.2 ± 0.9\       28.0 ± 0.0\       29.0 ± 2.0\       0.059
  (mean ± SD, range)                            28-32             28-28             28-32             

  Number of screws\                             2.7 ± 1.0,\       2.9 ± 1.1,\       2.0 ± 0.0,\       0.147
  (mean ± SD, range)                            2-6               2-6               2-2               
  -------------------------------------------------------------------------------------------------------------

SD: standard deviation

###### 

Clinical results.

  -----------------------------------------------------------------------------------------------------
  --                                 Total               Wedge Group         Curved Group     P Value
  ---------------------------------- ------------------- ------------------- ---------------- ---------
  Number of patients                 15                  12                  3                

  Number of hips                     18                  14                  4                

  JOA hip score before THA\          45.1 ± 16.3,\       46.1 ± 16.6,\       41.5 ± 17.1,\    0.630
  (mean ± SD, range)                 26-77               26-77               27-60            

  Pain (mean ± SD, range)            15.3 ± 8.5,\        15.4 ± 9.3,\        15.0 ± 5.8,\     0.943
                                     0-35                0-35                10-22            

  Gait (mean ± SD, range)            8.9 ± 4.4,\         8.9 ± 4.5,\         8.8 ± 4.8,\      0.945
                                     0-15                0-15                5-15             

  ROM (mean ± SD, range)             9.6 ± 5.0,\         10.4 ± 5.2,\        6.8 ± 3.4,\      0.209
                                     1-18                1-18                4-11             

  ADL (mean ± SD, range)             11.4 ± 3.2,\        11.5 ± 3.3,\        11.0 ± 3.5,\     0.792
                                     6-18                6-18                8-14             

  JOA hip score at last follow-up\   85.1 ± 10.9\*\*,\   82.5 ± 11.1\*\*,\   94.0 ± 2.8\*,\   P\<0.01
  (mean ± SD, range)                 62-96               62-96               90-96            

  Pain (mean ± SD, range)            35.3 ± 5.5,\        34.3 ± 5.8,\        38.8 ± 2.5,\     0.162
                                     20-40               20-40               35-40            

  Gait (mean ± SD, range)            16.4 ± 4.9,\        15.4 ± 5.1,\        20.0 ± 0.0,\     P\<0.01
                                     5-20                5-20                20-20            

  ROM (mean ± SD, range)             15.6 ± 1.7,\        15.2 ± 1.7,\        16.8 ± 1.0,\     0.110
                                     12-18               12-16               16-18            

  ADL (mean ± SD, range)             17.8 ± 1.7,\        17.6 ± 1.8,\        18.5 ± 1.0,\     0.340
                                     16-20               16-20               18-20            
  -----------------------------------------------------------------------------------------------------

THA: total hip arthroplasty

JOA: Japanese Orthopaedic Association

SD: standard deviation

ROM: range of motion

ADL: activity of daily living

\*p\<0.05, \*\*p\<0.01

###### 

Radiographic evaluation.

  ------------------------------------------------------------------------------------------------------------------
  --                                                          Total          Wedge Group    Curved Group   P Value
  ----------------------------------------------------------- -------------- -------------- -------------- ---------
  Number of patients                                          15             12             3              

  Number of hips                                              18             14             4              

  Cup abduction, degrees\                                     40.5 ± 5.0,\   40.5 ± 2.3,\   40.5 ± 4.0,\   0.986
  (mean ± SD, range)                                          32-51          32-51          37-46          

  Cup anteversion, degrees\                                   16.2 ± 6.5,\   18.0 ± 5.8,\   10.3 ± 5.9,\   P\<0.05
  (mean ± SD, range)                                          3.5-29.1       9.9-29.1       3.5-17.8       

  Number of cups in malposition, n (%)                        3 (17%)        2 (14%)        1 (25%)        0.612

  Number of stems in malposition (varus-valgus), n (%)        1 (6%)         1 (7%)         0 (0%)         0.582

  Number of stems in malposition (flexion-extension), n (%)   3 (17%)        3 (21%)        0 (0%)         0.310
  ------------------------------------------------------------------------------------------------------------------

SD: standard deviation
